CLINICAL_TRIALS
trial_result
· 2019-04-23
Clinical Trial Update: Glutamatergic Modulation of Disordered Alcohol Use [Phase 2, Phase 3]
Summary
Phase 2/3 clinical trial update on glutamatergic modulation for alcohol dependence; completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Alcohol Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-04-23